September 19th 2024
In a recent study, very preterm birth rates were reduced during COVID-19 lockdown periods vs prepandemic periods.
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant ...
November 20, 2024
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
STI diagnoses have increased in Europe despite social and physical distancing measures
November 5th 2020New research suggests that, despite COVID-19 lockdown restrictions, diagnoses of sexually transmitted infections (STIs), including gonorrhea, secondary syphilis and mycoplasma genitalium have increased.
Read More
NIH RADx initiative advances new COVID-19 testing technologies
October 6th 2020In collaboration with the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH) announced a third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies.
Read More
Mental health support is critical during pandemic
October 6th 2020The very measures used to prevent the spread of COVID-19 increase the risk of depression and suicidal thoughts: economic stress, social isolation, decreased access to community, barriers to mental health treatment, and illness.
Read More
Johnson & Johnson’s COVID-19 vaccine candidate enters phase 3 trial
September 24th 2020The investigational vaccine produced positive interim results in the company’s 1/2a clinical study, which showed that the safety profile and immunogenicity after a single vaccination were supportive of further development.
Read More